Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

62,226 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Expert consensus on microtransplant for acute myeloid leukemia in elderly patients -report from the international microtransplant interest group.
Ai H, Chao NJ, Rizzieri DA, Huang X, Spitzer TR, Wang J, Guo M, Keating A, Krakow EF, Blaise D, Ma J, Wu D, Reagan J, Gergis U, Duarte RF, Chaudhary PM, Hu K, Yu C, Sun Q, Fuchs E, Cai B, Huang Y, Qiao J, Gottlieb D, Schultz KR, Liu M, Chen X, Chen W, Wang J, Zhang X, Li J, Huang H, Sun Z, Li F, Yang L, Zhang L, Li L, Liu K, Jin J, Liu Q, Liu D, Gao C, Fan C, Wei L, Zhang X, Hu L, Zhang W, Tian Y, Han W, Zhu J, Xiao Z, Zhou D, Zhang B, Jia Y, Zhang Y, Wu X, Shen X, Lu X, Zhan X, Sun X, Xiao Y, Wang J, Shi X, Zheng B, Chen J, Ding B, Wang Z, Zhou F, Zhang M, Zhang Y, Sun J, Xia B, Chen B, Ma L. Ai H, et al. Among authors: zhang l, zhang m, zhang b, zhang w, zhang x, zhang y. Heliyon. 2023 Mar 31;9(4):e14924. doi: 10.1016/j.heliyon.2023.e14924. eCollection 2023 Apr. Heliyon. 2023. PMID: 37089296 Free PMC article. Review.
Ixazomib-based frontline therapy followed by ixazomib maintenance in frail elderly newly diagnosed with multiple myeloma: a prospective multicenter study.
Bao L, Wang YT, Liu P, Lu MQ, Zhuang JL, Zhang M, Xia ZJ, Li ZL, Yang Y, Yan ZY, Jing HM, Dong F, Chen WM, Wu Y, Zhou HB, Fu R, Gong YP, Huang WR, Zhang YQ. Bao L, et al. Among authors: zhang m, zhang yq. EClinicalMedicine. 2024 Jan 25;68:102431. doi: 10.1016/j.eclinm.2024.102431. eCollection 2024 Feb. EClinicalMedicine. 2024. PMID: 38318126 Free PMC article.
Comparison of zuberitamab plus CHOP versus rituximab plus CHOP for the treatment of drug-naïve patients diagnosed with CD20-positive diffuse large B-cell lymphoma: a phase 3 trial.
Li Z, Jiang W, Zhou H, Cen H, Zhang M, Lv F, Zhang Q, Sun X, Liu L, Huang Y, Yang H, Gao S, He C, Yang W, Li W, Yu D, Yang Y, Cheng Y, Qian Z, Xiang Y, Guo Q, Xu B, Song Y, Zhang L, Lin L, Shen J, Yan F, Liu H, Zhang D, Wang J, Zhou M, Zhu X, Zhang W, Zhao W, Feng R, Zhang X, Jin J, Zhong M, Zhang M, Wang J, Jing H, Wang Z, Zhao H, Zhu J. Li Z, et al. Among authors: zhang l, zhang m, zhang q, zhang w, zhang d, zhang x. J Immunother Cancer. 2024 Oct 24;12(10):e008895. doi: 10.1136/jitc-2024-008895. J Immunother Cancer. 2024. PMID: 39455094 Free PMC article. Clinical Trial.
Chinese expert consensus on the non-invasive imaging examination pathways of stable coronary artery disease.
Chen YD, Fang WY, Chen JY, Fan ZM, Gao CY, Ge JB, He ZX, Huo Y, Li L, Li SJ, Lu XL, Lv B, Qian JY, Shi YJ, Shen ZJ, Wang J, Wang YN, Xu L, Yang L, Yu B, Zhang M, Yang JJ, Zhang SY, Zhang XL, Zhao SH, Zheng Y, Han YC, Zhi G. Chen YD, et al. Among authors: zhang sy, zhang xl, zhang m. J Geriatr Cardiol. 2018 Jan;15(1):30-40. doi: 10.11909/j.issn.1671-5411.2018.01.012. J Geriatr Cardiol. 2018. PMID: 29434623 Free PMC article. No abstract available.
Rationale, design, and baseline characteristics of Chinese registry in early detection and risk stratification of coronary plaques (C-STRAT) study.
Yang JJ, Shan DK, Xu L, Liang JF, Wang ZQ, Zhang M, Li M, Yang WJ, Xu JR, Zhang YG, Xia LM, Wang LH, Hu HJ, Yang ZG, Li T, Tian Q, Lyu XD, Chen YD. Yang JJ, et al. Among authors: zhang m, zhang yg. Chin Med J (Engl). 2021 Jan 5;134(7):870-872. doi: 10.1097/CM9.0000000000001307. Chin Med J (Engl). 2021. PMID: 33410625 Free PMC article. No abstract available.
Coexistence of a novel SV2B-ALK, EML4-ALK double-fusion in a lung poorly differentiated adenocarcinoma patient and response to alectinib: a case report and literature review.
Chen H, Zhang M, Bai L, Niu Y, Wang X, Jiang R, Wang Y, Feng Q, Wang B, Dai T, Yuan M, Chen R, Qi Y, Zhong D. Chen H, et al. Among authors: zhang m. Front Oncol. 2024 Dec 13;14:1453259. doi: 10.3389/fonc.2024.1453259. eCollection 2024. Front Oncol. 2024. PMID: 39735595 Free PMC article.
62,226 results
You have reached the last available page of results. Please see the User Guide for more information.